We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$180M
AUM Growth
+$6.46M
Cap. Flow
-$30.8M
Cap. Flow %
-17.07%
Top 10 Hldgs %
57.53%
Holding
51
New
2
Increased
3
Reduced
42
Closed
1

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$196K
2
DE icon
Deere & Co
DE
+$190K
3
ALXN
Alexion Pharmaceuticals
ALXN
+$52.4K
4
VMW
VMware, Inc
VMW
+$10.1K
5
ADBE icon
Adobe
ADBE
+$2.06K

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$29M
2
CAVM
Cavium, Inc.
CAVM
+$381K
3
KITE
Kite Pharma, Inc.
KITE
+$366K
4
MELI icon
Mercado Libre
MELI
+$217K
5
CELG
Celgene Corp
CELG
+$165K

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Technology 25.32%
3 Consumer Discretionary 24.58%
4 Communication Services 13.24%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KITE
51
DELISTED
Kite Pharma, Inc.
KITE
– –
-2,036
Closed -$366K
1 2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Bender Robert & Associates held 51 positions worth $180M, up 3.7% from $174M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Bender Robert & Associates withdrew a net $30.8M in Q4 2017, closing 1 position and reducing 42 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $366K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bender Robert & Associates opened a new position in Caterpillar worth $223K.

  • Bender Robert & Associates's largest Q4 2017 buy was Caterpillar: 1,414 shares worth $223K.
  • Bender Robert & Associates added most to Alexion Pharmaceuticals in Q4 2017, an estimated $52.4K increase.
  • Bender Robert & Associates's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $29M.
  • Bender Robert & Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $366K.
  • Bender Robert & Associates's ten largest holdings make up 58% of its $180M portfolio in Q4 2017.
  • Bender Robert & Associates opened 2 new positions and closed 1 in Q4 2017.
  • Bender Robert & Associates's portfolio value rose 3.7% quarter-over-quarter to $180M.

Based on Bender Robert & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.